GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pentixapharm Holding AG (XTER:PTP) » Definitions » Pre-Tax Income

Pentixapharm Holding AG (XTER:PTP) Pre-Tax Income : €-6.09 Mil (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pentixapharm Holding AG Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Pentixapharm Holding AG's pretax income for the six months ended in Jun. 2024 was €-1.89 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was €-6.09 Mil. Pentixapharm Holding AG's pretax margin was -2,125.84%.

During the past 3 years, Pentixapharm Holding AG's highest Pretax Margin was -2512.90%. The lowest was -25891.67%. And the median was -2932.20%.


Pentixapharm Holding AG Pre-Tax Income Historical Data

The historical data trend for Pentixapharm Holding AG's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pentixapharm Holding AG Pre-Tax Income Chart

Pentixapharm Holding AG Annual Data
Trend Dec21 Dec22 Dec23
Pre-Tax Income
-1.73 -0.78 -6.21

Pentixapharm Holding AG Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24
Pre-Tax Income - - -2.02 -4.19 -1.89

Competitive Comparison of Pentixapharm Holding AG's Pre-Tax Income

For the Biotechnology subindustry, Pentixapharm Holding AG's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pentixapharm Holding AG's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pentixapharm Holding AG's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Pentixapharm Holding AG's Pre-Tax Income falls into.


;
;

Pentixapharm Holding AG Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Pentixapharm Holding AG's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-6.161+0+-0.183+0.13+-8.8817841970013E-16
=-6.21

Pentixapharm Holding AG's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1.996+0+-0.094+0.198+0
=-1.89

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-6.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pentixapharm Holding AG  (XTER:PTP) Pre-Tax Income Explanation

Pentixapharm Holding AG's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-1.892/0.089
=-2,125.84%

During the past 3 years, Pentixapharm Holding AG's highest Pretax Margin was -2512.90%. The lowest was -25891.67%. And the median was -2932.20%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pentixapharm Holding AG Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Pentixapharm Holding AG's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Pentixapharm Holding AG Business Description

Traded in Other Exchanges
Address
Robert-Rossle-Street 10, Berlin, DEU
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic.

Pentixapharm Holding AG Headlines

No Headlines